Westmead Institute For Medical Research;Western Sydney Local Health District;Icahn School of Medicine at Mount Sinai
发明人:
Barbara Murphy,Philip J. O'Connell
申请号：
US15810861
公开号：
US10725026B2
申请日:
2017.11.13
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A method for identifying a kidney transplant recipient at an increased risk of developing interstitial fibrosis or tubular atrophy which comprises obtaining a post-transplant urine sample from the kidney transplant recipient； measuring the level of clusterin in the urine sample； comparing the level of clusterin in the patient sample to the level of clusterin in a control sample from the urine of a non-fibrotic kidney transplant recipient； diagnosing a kidney transplant recipient with a clusterin level that is significantly higher than the clusterin level in the control as being at an increased risk of developing interstitial fibrosis or tubular atrophy.
